Vietnam Pharmaceutical Market Outlook

1
Challenges Vietnam Pharmaceutical
2

• Vietnam Pharmaceutical market by Generic and
  Patented drugs, by Prescribed Drugs and OTC Drugs
  and Therapeutic Drugs (Metabolism and Nutritional
  Medicine, Cardiovascular, Central Nervous System,
  System Infection, Oncology, Musculoskeletal,
  Respiratory and Others) along with company
  profiles of DHG Pharma, Traphaco, Pymepharco, Ha
  Tey Pharmaceutical, Mekophar, Domesco,
  Imexpharma, OPC, Sanofi, GSK, AstraZeneca,
  Novartis, Roche, Pfizer, MSD and Bayer
• Rise in generic drug usage and growth in
  self-medication in Vietnam will foster the growth
  of Pharmaceutical industry in Vietnam.
• Government initiative to produce higher quality
  pharmaceuticals in Vietnam will impact the market
  positively.

3
Government has focused on developing research
facilities and training of local talent. Under
the biotechnology drive target by 2020,
government is helping pharmaceutical producers to
develop expertise through foreign assistance.
Governments push for production and utilization
of locally produced generic drugs will boost
usage of generic drugs. Therapeutic segments such
as oncology and diabetes management will continue
to witness high demand for patented drugs. Rise
in number of drug manufacturers will also aid in
rise of generic drug usage. Trend in
self-medication culture will continue to drive
OTC drugs sector at least in the near future.
Antibiotics, Vitamins and dietary supplements
will continue to attract heavy demand through OTC
channel.  
4
Analysts at Ken Research in their latest
publication Vietnam Pharmaceutical Market
Outlook To 2022 - by Generic and Patented drugs,
by Prescribed Drugs and OTC Drugs and Therapeutic
Drugs (Metabolism and Nutritional Medicine,
Cardiovascular, Central Nervous System, System
Infection, Oncology, Musculoskeletal,
Respiratory believe that incline in demand for
hepatic treatment, rise in health supplements and
increasing demand for traditional / herbal
medicines will have positive impact on market.
5
Vietnam Pharmaceutical market is expected to
register positive CAGR of around 15.6 during the
period 2017-2022. RD investment and investment
in local production of APIs will have positive
impact on the demand for Pharmaceutical
products. Public procurement of drugs is done
through bidding in which any company is free to
submit proposal. Domestic manufacturers in the
country produce generics with very less
investment in RD activities, presenting low
barriers to entry for any new player. The
government has increasingly favored generic drugs
produced locally in the recent procurement
biddings. Foreign companies are increasingly
investing in developing manufacturing
capabilities in Vietnam.
6
Future Outlook to Vietnam Pharmaceutical
Market The pharmaceutical market is expected to
record growth at a CAGR of during 2017-2022,
driven by rise in utilization of generic drugs,
especially those manufactured locally. Generic
drug usage will continue to rise in future owing
to rising number of drug manufacturers and
governments push for production and utilization
of locally produced. Prescribed drugs will
dominate the pharmaceutical market but there will
be increase in the OTC medication due to self
medication. Antibiotics, Vitamins and dietary
supplements will continue to attract heavy demand
through OTC channel. Demand for oncology drugs
and system infections medicine is expected to
become almost times the size in 2017 with
revenue contribution of USD million and USD
million in 2022. Respiratory drugs are
anticipated to register highest CAGR of to
reach USD million by 2022.
7
Pharmaceutical Market in Vietnam Vietnam
Pharmaceutical Market Vietnam Generic Drugs
Revenue Vietnam Patented Drug Revenue Prescribed
Drug Market Vietnam OTC Medicine Sales
Vietnam Growth Pharmaceutical Sales
Vietnam Challenges Vietnam Pharmaceutical
Therapeutic Drug Sales Vietnam Vietnam and
Dietary Supplement Sales Vietnam Antibiotic sales
Vietnam Vitamin Sales Vietnam Vietnam
Pharmaceutical Competition Future Pharmaceutical
Vietnam Launch of New Drugs in Vietnam Drugs
Procured by Public Hospitals in
Vietnam Comparative Analysis of Pharmaceutical
Companies in Vietnam DHG Pharma Vietnam Revenue
8
For more information on the research report,
refer to below link https//www.kenresearch.com/h
ealthcare/pharmaceuticals/vietnam-pharmaceutical-m
arket/143605-91.html Related Reports The US
Pharmaceutical Market Outlook to 2016 - Evolving
Opportunities in the Biologics Segment India
Online Healthcare Products Market Outlook to 2020
- Infusion of Online Marketplaces and Healthcare
Awareness to Shape Future Growth Saudi Arabia
Healthcare Market Outlook to 2019 - Rising
Lifestyle Diseases and Government Investment to
Spur Future Growth Contact UsKen ResearchAnkur
Gupta, Head Marketing CommunicationsAnkur_at_kenre
search.com91-9015378249
9
(No Transcript)